EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights

Halimatu Hassan, Charlotte Rawlinson, Yu-Long Lan iD, Stuart Jenkins iD, Ruoli Chen iD

Biomolecules · 20.11.2025 · 15 (11) · 1629

DOI: 10.3390/biom15111629 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.11.2025. Verfasst von Halimatu Hassan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Allied Health Professions and Pharmacy, Keele University, Staffordshire ST5 5BG, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Phagocytosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia are the resident immune cells of the CNS, maintaining brain homeostasis partially through phagocytosis. In Alzheimer’s disease (AD), microglial phagocytosis is significantly impaired, contributing to the accumulation of pathological aggregates. Microglial phenotypes are dynamic and can shift depending on the disease stage and local environment. While some subpopulations retain or enhance phagocytic activity, especially under inflammatory conditions, others lose their capacity to clear toxic debris effectively. This variability underscores the need for a more nuanced understanding of microglial regulation and function. This paper explores the dual role of microglial phagocytosis in AD and discusses the emerging insights into microglial heterogeneity and how phenotypic shifts affect phagocytic capacity throughout disease progression. A comprehensive understanding of microglial phagocytosis and its dysregulation in AD is essential for designing targeted treatments. Modulating microglial activity to enhance their protective roles without triggering harmful inflammation represents a promising direction for therapeutic intervention in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicrogliaPhagocytosisHumansAnimals

Stichwörter der Autor:innen

Alzheimer’s diseasemicroglianeurodegenerationneuroinflammationneuroprotectionphagocytosis

Autor:innen und Institutionen

  • School of Allied Health Professions and Pharmacy, Keele University, Staffordshire ST5 5BG, UK.
  • The ME Association, Gawcott, Buckinghamshire MK18 4DF, UK.
  • Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
  • Neural Tissue Engineering Keele (NTEK), School of Medicine, Keele University, Staffordshire ST5 5BG, UK.

ORCID-Profile: Yu-Long Lan, Stuart Jenkins, Ruoli Chen

Förderung

  • British Heart Foundation

Zitieren

APA

Hassan, H., Rawlinson, C., Lan, Y. L., Jenkins, S., & Chen, R. (2025). Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights. Biomolecules, 15(11), 1629. https://doi.org/10.3390/biom15111629

Vancouver

Hassan H, Rawlinson C, Lan YL, Jenkins S, Chen R. Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights. Biomolecules. 2025;15(11):1629. doi:10.3390/biom15111629

BibTeX
@article{Hassan2025,
  author = {Hassan, Halimatu and Rawlinson, Charlotte and Lan, Yu-Long and Jenkins, Stuart and Chen, Ruoli},
  title = {Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1629},
  doi = {10.3390/biom15111629}
}
Kostenlos starten →